Busey Trust CO reduced its holdings in shares of Johnson & Johnson (NYSE:JNJ) by 2.1% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 153,316 shares of the company’s stock after selling 3,340 shares during the quarter. Johnson & Johnson makes up 2.8% of Busey Trust CO’s investment portfolio, making the stock its 6th biggest holding. Busey Trust CO’s holdings in Johnson & Johnson were worth $20,282,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. River Wealth Advisors LLC boosted its position in shares of Johnson & Johnson by 4.9% in the 2nd quarter. River Wealth Advisors LLC now owns 14,410 shares of the company’s stock valued at $1,906,000 after purchasing an additional 679 shares during the period. Ironwood Investment Management LLC boosted its position in shares of Johnson & Johnson by 0.4% in the 2nd quarter. Ironwood Investment Management LLC now owns 5,074 shares of the company’s stock valued at $671,000 after purchasing an additional 20 shares during the period. Welch Investments LLC boosted its position in shares of Johnson & Johnson by 3.5% in the 2nd quarter. Welch Investments LLC now owns 35,107 shares of the company’s stock valued at $4,644,000 after purchasing an additional 1,190 shares during the period. Peoples Bank OH boosted its position in shares of Johnson & Johnson by 2.7% in the 2nd quarter. Peoples Bank OH now owns 9,440 shares of the company’s stock valued at $1,249,000 after purchasing an additional 250 shares during the period. Finally, Grove Bank & Trust boosted its position in shares of Johnson & Johnson by 66.1% in the 2nd quarter. Grove Bank & Trust now owns 5,187 shares of the company’s stock valued at $686,000 after purchasing an additional 2,065 shares during the period. 66.06% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Busey Trust CO Sells 3,340 Shares of Johnson & Johnson (JNJ)” was first posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/busey-trust-co-sells-3340-shares-of-johnson-johnson-jnj/1681816.html.

Shares of Johnson & Johnson (NYSE:JNJ) opened at $140.08 on Monday. The firm has a market capitalization of $376,327.72, a P/E ratio of 19.62, a P/E/G ratio of 2.85 and a beta of 0.82. The company has a quick ratio of 1.02, a current ratio of 1.32 and a debt-to-equity ratio of 0.36. Johnson & Johnson has a fifty-two week low of $109.32 and a fifty-two week high of $144.35.

Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings results on Tuesday, October 17th. The company reported $1.90 earnings per share for the quarter, topping analysts’ consensus estimates of $1.80 by $0.10. The business had revenue of $19.65 billion for the quarter, compared to analysts’ expectations of $19.29 billion. Johnson & Johnson had a return on equity of 27.38% and a net margin of 21.28%. The company’s revenue was up 10.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.68 EPS. analysts expect that Johnson & Johnson will post 7.28 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Tuesday, November 28th will be issued a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.40%. The ex-dividend date of this dividend is Monday, November 27th. Johnson & Johnson’s dividend payout ratio is currently 58.33%.

A number of brokerages recently issued reports on JNJ. Vetr raised Johnson & Johnson from a “sell” rating to a “hold” rating and set a $137.71 target price for the company in a research report on Monday, October 30th. Citigroup Inc. upped their target price on Johnson & Johnson from $140.00 to $149.00 and gave the company a “buy” rating in a research report on Monday, October 23rd. Credit Suisse Group set a $154.00 target price on Johnson & Johnson and gave the company an “outperform” rating in a research report on Thursday, October 19th. Jefferies Group LLC upped their target price on Johnson & Johnson from $157.00 to $160.00 and gave the company a “buy” rating in a research report on Monday, October 16th. Finally, Barclays PLC upped their target price on Johnson & Johnson from $140.00 to $148.00 and gave the company an “equal weight” rating in a research report on Wednesday, October 18th. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating and eleven have issued a buy rating to the company’s stock. Johnson & Johnson currently has an average rating of “Hold” and a consensus target price of $143.70.

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with Analyst Ratings Network's FREE daily email newsletter.